| Literature DB >> 19454021 |
Lalitha Peddireddi1, Chuanmin Cheng, Roman R Ganta.
Abstract
BACKGROUND: Ehrlichia chaffeensis is a rickettsial agent responsible for an emerging tick-borne illness, human monocytic ehrlichiosis. Recently, we reported that E. chaffeensis protein expression is influenced by macrophage and tick cell environments. We also demonstrated that host response differs considerably for macrophage and tick cell-derived bacteria with delayed clearance of the pathogen originating from tick cells.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19454021 PMCID: PMC2694197 DOI: 10.1186/1471-2180-9-99
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Primer extension (PE) analysis of p28-Omp genes 14 and 19. Panel A has a cartoon spanning all 22 genes [37]. This panel also has an expansion of cartoons for genes 14 and 19 with predicted transcripts, the primers used for the PE analysis and sequences of the primer extended products with transcription start sites identified with asterisks. PE analysis products resolved on a sequencing gel are shown in panel B. Blots on the left and right represent the data for transcripts of genes 14 and 19, respectively. A sequence ladder for the gene 14 analysis was prepared by using the same primer used for the PE analysis but with a DNA template spanning the gene 14 sequence. For gene 19, PE analysis was performed with RRG 44 primer, and the sequencing ladder was generated by using RRG20-PEXT primer with a gene 19 DNA template. (Lane 1, E. chaffeensis RNA from tick cells; lane 2, E. chaffeensis RNA from macrophages).
Figure 2Quantitative RT-PCR analysis. TaqMan-based quantitative RT-PCR analysis was performed with RNA isolated from tick cell (A) and macrophage (B) cultures harvested at different times postinfection. Transcript numbers were estimated and presented per million E. chaffeensis organisms. Data are presented with SE values calculated from three independent experiments (P ≤ 0.05).
Figure 3P28-Omp genes 14 and 19 promoter region sequence analysis. Upstream sequences of genes 14 (panel A) and 19 (panel B) were evaluated for the presence of direct repeats (red text), palindromic sequences (pink text) and for the presence of unique sequences (G-rich region), consensus -35 and -10 regions (green text) and ribosome binding sites (blue text). Panel C shows the comparison of -10, -35 and ribosome binding sites of genes 14 and 19 with the E. coli consensus sequences. Transcription start sites for the genes mapped by primer extension analysis are identified with bold and grey color highlighted text or with an asterisk. Dashes were introduced in the p28-Omp gene 19 sequence to create alignment with the gene 14 sequence.
Figure 4. In vitro transcription analysis was performed for the complete upstream sequences of genes 14 and 19 in forward and reverse orientations ligated to a partial lacZ gene segment (301 bp) (solid black boxes). The orientation of ligated promoter regions is shown by arrowhead lines (right arrowhead line, forward orientation; left arrowhead line, reverse orientation). Wiggled arrowhead lines show predicted transcripts of 335 bases for gene 14 and 327 bases for gene 19. Sequence segments and the predicted transcripts for genes 14 and 19 are shown as cartoons on the left, and the observed transcripts are shown on the right of the panels. Puc18 plasmid DNA was used as the template to generate a sequence ladder with an M13 forward primer. Numbers 1 and 2 refer to the constructs for in vitro transcription for gene 14, and 3 and 4 refer to in vitro transcription templates for gene 19.
Figure 5(A) Green fluorescent protein (GFP) constructs evaluated for the promoter activity of p28-Omp genes 14 and 19. The pPROBE-NT plasmids containing the promoterless GFP gene (2 and 3) and upstream sequences of genes 14 and 19 in front of the GFP gene (1 and 4, respectively) and a construct containing no promoter sequence were evaluated for GFP expression in E. coli. (B) LacZ constructs evaluated for the promoter activity of p28-Omp genes 14 and 19. The pBlue-TOPO vector containing promoterless lacZ gene (pBlue-TOPO) and upstream sequences of genes 14 and 19 inserted in forward (14-F and 19-F) and reverse orientations (14-R and 19-R) were evaluated for β-galactosidase activity in E. coli. Data are presented with SD values calculated from four independent experiments (P ≤ 0.001).
Figure 6Deletion analysis of promoter regions of genes 14 and 19. β-galactosidase activity of extracts prepared from E. coli cultures of bacteria transformed with various deletion constructs was determined. Panels A and C have cartoons depicting deletion constructs and their orientations for genes 14 and 19, respectively. (Solid black boxes represent lacZ gene, and right and left arrowhead lines show orientation of the promoter regions ligated in front of the lacZ coding sequence. Lengths of the promoter regions in base pairs are indicated on the left. Panels B and D contain the β-galactosidase activity analysis data. (β-galactosidase activity was expressed as percent activity relative to the activity observed for full length promoter segments.) Data are presented with SD values calculated from four independent experiments (P ≤ 0.001).
Figure 7Deletion analysis spanning the -35 and -10 regions of genes 14 and 19. β-galactosidase activity of extracts prepared from E. coli cultures of bacteria transformed with -35 or -10 deletions or deletions spanning from -35 to 10 were determined. Panels A and C have cartoons depicting deletion constructs and their orientations for genes 14 and 19, respectively. Panels B and D contained the β-galactosidase activity analysis data. Data are presented with SD values calculated from four independent experiments (P ≤ 0.001).
List of oligonucleotides used for this study
| Primers | Sequence | Orientation | Amplicon size | Annealing temperature |
|---|---|---|---|---|
| RRG 183* | 5' GACTCTAGAttgctcaacccataaaataatg | Forward | 596 | 50 |
| RRG 184 | 5' AGTGAGCTCtttataaaagataataaaaatttaag | Reverse | ||
| RRG 217 | 5' attgctcaaccataaaataatggga | Forward | 581 | 48 |
| RRG 218 | 5' gttaataaaccttttataaaag | Reverse | ||
| RRG 267 | 5' cagttaactttctgtaaacttc | Forward | 521 | 48 |
| RRG 218** | Reverse | |||
| RRG 268 | 5' atcataagtttacaataatgtc | Forward | 461 | 48 |
| RRG 218 | Reverse | |||
| RRG 269 | 5' cgttttctgctttattagaatg | Forward | 400 | 48 |
| RRG 218 | Reverse | |||
| RRG 270 | 5' gttccgtatttattaatatatg | Forward | 350 | 48 |
| RRG 218 | Reverse | |||
| RRG 271 | 5' catgtactgaatttgtgatttg | Forward | 286 | 48 |
| RRG 218 | Reverse | |||
| RRG 272 | 5' ggataagtactttagcaagtgg | Forward | 222 | 48 |
| RRG 218 | Reverse | |||
| RRG 273 | 5' taagtagtaaagttaactatag | Forward | 169 | 48 |
| RRG 218 | Reverse | |||
| RRG 274 | 5' acttttgttgtaaatttgaaag | Forward | 105 | 48 |
| RRG 218 | Reverse | |||
| RRG 217 | Forward | 516 | 50 | |
| IG14-35 del R | 5' (PO4)-gtctagaatataaaatttctttc | Reverse | ||
| IG14-10 del F | 5' (PO4)-taaatttttattatcttttataaaaggtttattaac | Forward | 8366 | 56 |
| IG14-10 del R | 5' (PO4)-atgaaagaaataaagaaaagcaagtctag | Reverse | ||
| IG14-35 del F | 5' (PO4)-ttctttatttctttcattattc | Forward | 8366 | 48 |
| IG14-35 del R | Reverse | |||
| IG14-10 del F | Forward | 8343 | 51 | |
| IG14-35 del R | Reverse | |||
| RRG 185 | 5' GACTCTAGActtttaattttattattgccacatg | Forward | 334 | 61 |
| RRG 186 | 5' AGTGAGCTCaatagtgacaaataaattaacaatag | Reverse | ||
| RRG 185 | Forward | 308 | 60 | |
| RRG 445 | 5' atataacctaatagtgacaaataaattaac | Reverse | ||
| RRG 275 | 5' gtggcaaaagaatgtagcaataag | Forward | 239 | 50 |
| RRG 445 | Reverse | |||
| RRG 276 | 5' gtgctgtttttctcacctttacac | Forward | 188 | 63 |
| RRG 445 | Reverse | |||
| RRG 277 | 5' ctgacgtaatatattaaattttcc | Forward | 125 | 55 |
| RRG 445 | Reverse | |||
| RRG 185 | Forward | 267 | 50 | |
| IG19-35 del R | 5' (PO4)-gtcagaatataaatttttgtataaaatatcg | Reverse | ||
| IG19-10 del F | 5' (PO4)-taatttatttgtcactattaggttat | Forward | 8112 | 56 |
| IG19-10 del R | 5' (PO4)-gtagaagtgtcatataaaagcaag | Reverse | ||
| IG19-35 del F | 5' (PO4)-ttatatgacacttctactattgttaatttatttg | Forward | 8112 | 61.5 |
| IG19-35 del R | Reverse | |||
| IG19-10 del F | Forward | 8088 | 58 | |
| IG19-35 del R | Reverse | |||
| RRG 14-5'rev | 5' gccttctctgctgtcgttgattcc | NA | 52 | |
| RRG 20-PEXT | 5' cgttaataccactacctgctgggtcg | NA | 58 | |
| RRG 44 | 5' cgcttccgtcccaattttgcttc | NA | 58 | |
| RRG 217 | 5' attgctcaaccataaaataatggga | Forward | 882 | 50 |
| RRG 226 | 5' cgccattcgccattag | Reverse | ||
| RRG 218 | 5' gttaataaaccttttataaaag | Forward | 882 | 50 |
| RRG 226 | Reverse | |||
| RRG 217 | 5' attgctcaaccataaaataatggga | Forward | 601 | 50 |
| RRG 226 | Reverse | |||
| RRG 445 | 5' atataacctaatagtgacaaataaattaac | Forward | 601 | 50 |
| RRG 226 | Reverse | |||
| RRG 185 | 5' gactctagacttttaattttattattgccacatg | Forward | 848 | 58 |
| RRG 247 | 5' tccggctcgtatgttgtgtg | Reverse | ||
* Text in capital letters refers to sequences inserted for creating restriction enzyme sites. ** Primer sequences were presented only once when a primer was described for the first time.